Bdh Industries Ltd Stock Price Today (NSE: BDH)
Fundamental Score
Bdh Industries Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Bdh Industries Ltd share price today is ₹456.15, up +1.39% on NSE/BSE as of 17 June 2026. Bdh Industries Ltd (BDH) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹213.46 (Cr). The 52-week high for BDH share price is ₹523.75 and the 52-week low is ₹257.05. At a P/E ratio of 21.89x, BDH is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 14.16% and a debt-to-equity ratio of 0.00.
Bdh Industries Ltd Share Price Chart — NSE/BSE Historical Performance
Bdh Industries Ltd share price chart: -7.02% return over the past month. 52-week high ₹523.75, 52-week low ₹257.05.
Bdh Industries Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹360.10 | ₹369.90 | ₹351.05 | ₹351.45 | 3.19K (Cr) | |
| ₹360.10 | ₹368.75 | ₹359.50 | ₹367.80 | 601.00 (Cr) | |
| ₹365.00 | ₹374.40 | ₹357.20 | ₹359.45 | 1.25K (Cr) | |
| ₹368.90 | ₹368.90 | ₹359.25 | ₹366.80 | 453.00 (Cr) | |
| ₹370.00 | ₹370.00 | ₹355.05 | ₹359.25 | 1.11K (Cr) | |
| ₹364.95 | ₹376.80 | ₹357.90 | ₹358.15 | 269.00 (Cr) | |
| ₹373.00 | ₹377.00 | ₹342.00 | ₹360.00 | 2.83K (Cr) | |
| ₹366.00 | ₹376.25 | ₹363.00 | ₹367.00 | 810.00 (Cr) | |
| ₹363.90 | ₹372.90 | ₹355.10 | ₹371.60 | 442.00 (Cr) | |
| ₹360.00 | ₹369.00 | ₹357.00 | ₹363.90 | 972.00 (Cr) |
Bdh Industries Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹360.10 | ₹369.90 | ₹351.05 | ₹351.45 | -2.40% | |
| ₹375.00 | ₹379.85 | ₹342.00 | ₹359.45 | -4.15% | |
| ₹355.40 | ₹395.00 | ₹355.30 | ₹377.35 | +6.18% | |
| ₹430.00 | ₹448.00 | ₹340.15 | ₹352.70 | -17.98% | |
| ₹373.40 | ₹458.90 | ₹360.00 | ₹402.40 | +7.77% | |
| ₹425.45 | ₹433.50 | ₹368.00 | ₹376.05 | -11.61% | |
| ₹379.85 | ₹452.25 | ₹350.00 | ₹425.45 | +12.00% | |
| ₹416.80 | ₹479.90 | ₹370.05 | ₹374.85 | -10.06% | |
| ₹464.90 | ₹523.75 | ₹411.70 | ₹416.85 | -10.34% | |
| ₹321.00 | ₹465.00 | ₹302.15 | ₹454.45 | +41.57% | |
| ₹300.00 | ₹333.00 | ₹272.20 | ₹327.30 | +9.10% | |
| ₹263.00 | ₹353.70 | ₹257.40 | ₹310.70 | +18.14% |
AI Research Briefing
Powered by Gemini · 2026-04-08
Microcap pharma play hinges on consistent order execution and transparency, with liquidity a constant threat.
WHAT'S HAPPENING NOW (last 2-4 weeks)
BDH Industries secured a Cr purchase order on April 2, 2026, to supply 'Spacer' to a domestic client, with delivery expected by August 31, 2026. The client's identity remains confidential.
CORE STORY (THE REAL GAME)
BDH is a microcap pharma play, but the real game is whether they can consistently secure and execute orders to justify a re-rating. This isn't about blockbuster drugs; it's about consistent execution in a fragmented market.
- ₹10.08 Cr order win provides near-term revenue visibility
- Relatively lower P/E compared to industry average
- Positive sentiment in the Indian pharma sector
- Successful execution of the ₹10.08 Cr order
- New order wins with disclosed client names
- Significant earnings beat in upcoming quarters
- Microcap illiquidity
- Opacity around client details for the recent order
- Low Sales CAGR 5Y of 2.26%
FII holding is negligible at 0.28% with no change. No institutional conviction.
Indian pharma sector expected to grow significantly, but faces increasing competition and regulatory scrutiny.
₹10.08 Cr order to supply 'Spacer' to a domestic client, delivery by August 31, 2026
Free Cash Flow 5Y: ₹21.38 Cr. Profit converting to cash, but not consistently.
Near-term focus on executing the recent order. Long-term growth depends on securing new contracts and expanding into higher-margin products.
Primary Thesis Risk
Failure to execute the ₹10.08 Cr order or secure new contracts will decimate the stock.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Bdh Industries Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Bdh Industries Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of BDH across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Excellent ROCE Performance (17.82%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 21.89 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (16.82%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (221.33x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Limited Growth History (2.26% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Limited Institutional Interest (FII+DII: 0.28%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Bdh Industries Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Bdh Industries Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Bdh Industries LtdBdh Industries ...Selected✓ BDH • 524828 | 53.8/100 | ₹456.15₹456 | ₹213.46₹213.46 | 21.89Average 21.9 Average | 14.16%Average 14.16% Average | 17.82%Good 17.82% Good | 0.00Excellent 0.0 Excellent | 9.31%Good 9.31% Good | 2.26%Average 2.26% Average | 1.21% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1782.20₹1782 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6623.00₹6623 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4420.90₹4421 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1401.30₹1401 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1278.20₹1278 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2267.70₹2268 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹1089.00₹1089 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2336.10₹2336 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1462.30₹1462 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5251.50₹5252 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Bdh Industries Ltd PE Ratio History
Historical price-to-earnings ratio for BDH — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹17.14 | ₹346.35 | 20.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Bdh Industries Ltd Dividend History
Annual cash dividends paid by BDH — dividend yield 1.21%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹2.59 Cr |
| FY 2024 | ₹2.30 Cr |
| FY 2023 | ₹2.07 Cr |
| FY 2022 | ₹1.73 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Bdh Industries Ltd Quarterly Performance
Latest quarterly metrics for BDH — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
16.82%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
8.71%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
2.26%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
9.31%
Compounded annual net profit growth over 5 years
Bdh Industries Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for BDH — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Bdh Industries Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Bdh Industries Ltd (BDH) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Bdh Industries Ltd
About BDH (Bdh Industries Ltd)
BDH Industries Ltd is a multifaceted pharmaceutical company deeply rooted in the Indian market, yet expanding its global footprint with a dedication to therapeutic solutions. They ...are the makers of a broad portfolio of pharmaceutical formulations crafted to address a wide range of medical needs. From common ailments to more complex conditions, BDH formulates, manufactures, and distributes vital medications that enhance well-being. Their product list is diverse, including essential medications, and reflects a commitment to making a positive impact on global healthcare. BDH operates through a dual-pronged business model, encompassing pharmaceuticals and renewable energy, demonstrating a forward-thinking approach to sustainability. The pharmaceutical arm is the core of their operations, where cutting-edge research, rigorous testing, and advanced manufacturing processes converge to produce safe and effective drugs. Simultaneously, the renewable energy segment underscores BDH's commitment to environmental responsibility, working towards a cleaner and more sustainable future. This synergy of healthcare and sustainability positions BDH as a company invested in holistic well-being. BDH is committed to providing access to quality medicines for various therapeutic areas. They create solutions for pain relief, digestive health, and various infectious diseases. They also address mental health and respiratory health issues. Through strategic partnerships and a robust distribution network, they are dedicated to making their formulations available to patients worldwide. With a strong focus on ethical practices and a dedication to research, BDH strives to meet the evolving needs of the healthcare industry.
Company Details
Key Leadership
Corporate Events
BDH Share Price: Frequently Asked Questions
What is the current share price of Bdh Industries Ltd?
Bdh Industries Ltd (BDH) trades at ₹456.15 on NSE and BSE. Market cap ₹213.46 (Cr). Educational data only.
What is the P/E ratio of Bdh Industries Ltd?
Bdh Industries Ltd has a P/E of 21.89x vs industry average 31.77x.
What is the Bull Run score for Bdh Industries Ltd?
Bdh Industries Ltd has a Bull Run score of 53.8/100 based on 25+ financial parameters.
Does Bdh Industries Ltd pay dividends?
Bdh Industries Ltd has a dividend yield of 1.21%. Past dividends don't guarantee future payments.
What is the ROE of Bdh Industries Ltd?
Bdh Industries Ltd has ROE of 14.16%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Bdh Industries Ltd?
Bdh Industries Ltd has debt-to-equity of 0.00.
Is Bdh Industries Ltd a good investment?
Bull Run gives Bdh Industries Ltd a score of 53.8/100. This is not investment advice — consult a SEBI-registered advisor.